Oral health conditions affect functional and social activities of terminally ill cancer patients

被引:46
作者
Fischer, D. J. [1 ]
Epstein, J. B. [2 ,3 ]
Yao, Y. [4 ,5 ]
Wilkie, D. J. [4 ,5 ]
机构
[1] Univ Illinois, Coll Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60612 USA
[2] Cedars Sinai Hlth Syst, Samual Oschin Comprehens Canc Inst, Los Angeles, CA USA
[3] City Hope Natl Med Ctr, Div Otolaryngol Head & Neck Surg, Duarte, CA 91010 USA
[4] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA
[5] Univ Illinois, Coll Nursing, Ctr Excellence End Life Transit Res, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
Terminally ill; Cancer; Mouth diseases; Pain; Functional and social impact; Hospice; Palliative care; QUALITY-OF-LIFE; SALIVARY FLOW; XEROSTOMIA; DEHYDRATION; CANDIDOSIS; PREVALENCE; STRATEGIES; NUTRITION; HYDRATION; SYMPTOMS;
D O I
10.1007/s00520-013-2037-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral conditions are established complications in terminally ill cancer patients. Yet despite significant morbidity, the characteristics and impact of oral conditions in these patients are poorly documented. The study objective was to characterize oral conditions in terminally ill cancer patients to determine the presence, severity, and the functional and social impact of these oral conditions. This was an observational clinical study including terminally ill cancer patients (2.5-3-week life expectancy). Data were obtained via the Oral Problems Scale (OPS) that measures the presence of subjective xerostomia, orofacial pain, taste change, and the functional/social impact of oral conditions and a demographic questionnaire. A standardized oral examination was used to assess objective salivary hypofunction, fungal infection, mucosal erythema, and ulceration. Regression analysis and t test investigated the associations between measures. Of 104 participants, most were a parts per thousand yen50 years of age, female, and high-school educated; 45 % were African American, 43 % Caucasian, and 37 % married. Oral conditions frequencies were: salivary hypofunction (98 %), mucosal erythema (50 %), ulceration (20 %), fungal infection (36 %), and other oral problems (46 %). Xerostomia, taste change, and orofacial pain all had significant functional impact; p < .001, p = .042 and p < .001, respectively. Orofacial pain also had a significant social impact (p < .001). Patients with oral ulcerations had significantly more orofacial pain with a social impact than patients without ulcers (p = .003). Erythema was significantly associated with fungal infection and with mucosal ulceration (p < .001). Oral conditions significantly affect functional and social activities in terminally ill cancer patients. Identification and management of oral conditions in these patients should therefore be an important clinical consideration.
引用
收藏
页码:803 / 810
页数:8
相关论文
共 40 条
  • [1] Aldred M J, 1991, Spec Care Dentist, V11, P59
  • [2] Palliative performance scale (PPS): A new tool
    Anderson, F
    Downing, GM
    Hill, J
    Casorso, L
    Lerch, N
    [J]. JOURNAL OF PALLIATIVE CARE, 1996, 12 (01) : 5 - 11
  • [3] [Anonymous], 2011, R: A language and environment for statistical computing
  • [4] High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer
    Bagg, J
    Sweeney, MP
    Lewis, MAO
    Coleman, D
    Al Mosaid, A
    Baxter, W
    McEndrick, S
    McHugh, S
    [J]. PALLIATIVE MEDICINE, 2003, 17 (06) : 477 - 481
  • [5] Caro MMM, 2007, CLIN NUTR, V26, P289, DOI 10.1016/j.clnu.2007.01.005
  • [6] Chaushu G, 2000, CANCER, V88, P984, DOI 10.1002/(SICI)1097-0142(20000301)88:5<984::AID-CNCR6>3.3.CO
  • [7] 2-S
  • [8] Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
  • [9] A comparison of inclusive and restrictive strategies in modern missing data procedures
    Collins, LM
    Schafer, JL
    Kam, CM
    [J]. PSYCHOLOGICAL METHODS, 2001, 6 (04) : 330 - 351
  • [10] Oral yeast carriage in patients with advanced cancer
    Davies, AN
    Brailsford, S
    Broadley, K
    Beighton, D
    [J]. ORAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 17 (02): : 79 - 84